Ophthalmic start-up Iantech, Inc. has recently received investment funding from the Global Health Investment Fund (GHIF) and Visionary Venture Fund that will be used to further R&D and commercial efforts for its miLOOP cataract surgery technology.
The miLOOP is a pen-like device that reportedly allows for energy-free lens fragmentation through a minimally invasive clear cornea incision. It reportedly uses a first-in-class nitinol micro-filament technology to fragment the lens for removal through a micro-incision, which helps to make cataract removal more efficient and less invasive.
The miLOOP device is reportedly now commercially available in select U.S. markets and can be used with industry-standard phacoemulsification techniques
Click here to read the full press release.
Like what you read? Follow OphthalmologyWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.
Source: Global Health Investment Fund (GHIF)